|
MORE DETAILS
|
WEEKLY COMMENT
|
Every Tuesday we send out the MedComms Networking email newsletter to subscribers. It includes brief commentary on what we're doing and planning, and highlights relevant news to encourage sharing of information, experiences and ideas and to stimulate discussion. The text and links included below, by definition, were accurate on the day of publication, but may then become outdated.
|
|
MedComms Networking - 27 October 2020
Hi
This week's hot news is publication of the 1st edition of our brand new annual FirstMedCommsJob careers guide, authored by John Gonzalez and supported by Envision Pharma Group. Ensuring timely dissemination of research: a guide to working as a medical publications professional is now freely accessible, along with our other annual guides at FirstMedCommsJob.com.
As always, I'd love to hear your feedback. Note I'll be joined by John and some of the Envision Pharma team online for our #MedComms webinar on 2 December, when we'll talk about Working as a medical publications professional.
That's six issues in our unique series of annual guides, and completes the set for 2020.
Now I'm working on the new (4th) edition of our guide, The business of medical communications: a guide to getting started in account management authored by Lindsey Heer. That'll be published in January. Let me know if you want to make sure your company is included.
Meanwhile, last week was Open Access week 2020 and our contribution was an expert panel session put together with support from the Open Pharma team - Publishing open access saves lives. Chris Winchester (Oxford PharmaGenesis), Durhane Wong-Rieger (the Canadian Organization for Rare Disorders), Valerie Philippon (Takeda) and Gavin Sharrock (Wiley) discussed what's happening about open access across the pharma industry and how you can make a difference within your organization. Watch the recording here.
Please take a moment to read and support the Open Pharma Position statement on open access.
Importantly, last week Galapagos committed to an open access policy. That makes it only the third pharmaceutical company to introduce such a policy as part of its commitment to transparency.
I get somewhat frustrated that we've been talking about this for 10 years and more. Progress is slow. Why is that?
Maybe this resource will help some of you move the agenda forwards within your own organisation. Last week, Open Pharma launched a set of educational slides that can be used in conversations and engagements advocating for open access and the open science movement. Access the slides here.
Next up, in tomorrow's webinar we're talking about The future of medcomms including congresses in a post COVID-19 era with the team from Prime Global. We've a good crowd gathering again.
Then next week we're going to try and provoke a wider discussion across the MedComms community around Equity, diversity and inclusion. Everyone's welcome. Please spread the word.
Here's some useful reading in preparation...
Published last week in The MAP Newsletter from ISMPP, Equity, Diversity, and Inclusion: Defining a Roadmap for Our Profession, by Catherine Skobe (Pfizer), Angela Sykes (Pfizer) and Chris Winchester (Oxford PharmaGenesis)
This month from PharmaTimes, Embracing diversity by Shairose Ebrahim (imc group)
Last month from pharmaphorum, How companies can encourage more diversity and inclusion in pharma by David Peacock (MSD)
Remember, details of all our activities are kept bang up-to-date at www.MedCommsNetworking.com or give me a shout at any time if you've any questions, comments or suggestions.
Stay safe and well, everyone.
Cheers
Peter Llewellyn
Managing Director, NetworkPharma Ltd
Follow me on Twitter @NetworkPharma
Join 4,000 international colleagues in the MedComms Networking Linkedin Group
The information at www.MedCommsNetworking.com is always bang up-to-date!
|
|
|
|
